A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats

ConclusionThe EN  + RAL treatment appeared to be promising in preventing male osteoporosis, but given the observed side effects on liver, kidney, and prostate weights, it requires further investigation.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research